AnaPath Services & AnaPath Research S.A.U.
Guk-Jin Son currently serves as the CEO and Korea Representative for AnaPath Services & AnaPath Research S.A.U. since November 2020. Prior to this role, Guk-Jin held the position of Head of Business Development at Ginapath, Co., Ltd from October 2014 to September 2020, where responsibilities included supporting new drug and biosimilar development, overseeing contract manufacturing and research, and consulting on drug development processes. Guk-Jin's career also includes experience as the Manager of Business Development at CMIC Korea and Harlan Laboratories, where a focus on new drug development, non-clinical and clinical studies, and strategic consulting for drug development was emphasized.
This person is not in any offices
AnaPath Services & AnaPath Research S.A.U.
AnaPath, is a global company including contract research organization (CRO) and pathology services that provides R &D services in the preclinical and bioanalytical fields. AnaPath is formed by two main sections: AnaPath Services, based in Switzerland and focused on pathology, and AnaPath Research, based on Barcelona and focused in preclinical development. AnaPath Services emanates from RCC/Harlan and was established in 2013. It is located close to the pharmaceutical capital Basel and has a surprisingly wide experience for a young company due to company due to its history. AnaPath Services is recognized for the scientific competence in toxicologic pathology, high operational speed and reliability. The current AnaPath Research was Founded in 1980, as CIDASAL, the site had been part of multiple international companies such as RCC, Harlan and Envigo , always providing high quality services to our sponsors. In the late 2019, AnaPath services acquire the site and started a journey to the excellence of research. AnaPath is structured in departments according to the field of the services we offer, and in perfect coordination. General Toxicology performs a full range of studies to support the pharmaceutical, chemical, agrochemical and veterinary industries. The studies are performed to fulfill global regulatory guidelines in accordance with GLP (Good Laboratory Practices).